Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.07
-0.11 (-0.83%)
At close: Aug 24, 2026, 4:00 PM EDT
13.07
0.00 (0.00%)
After-hours: Aug 24, 2026, 7:30 PM EDT
Korro Bio Employees
Korro Bio had 57 employees as of June 30, 2026. The number of employees decreased by 35 or -38.04% compared to the same quarter last year.
Employees
57
Change
-35
Growth
-38.04%
Revenue / Employee
$41,789
Profits / Employee
-$1,870,947
Market Cap
192.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 57 | -35 | -38.04% | 57 | 0 |
| Mar 31, 2026 | 49 | -63 | -56.25% | 49 | 0 |
| Dec 31, 2025 | 58 | -46 | -44.23% | 58 | 0 |
| Sep 30, 2025 | 87 | -8 | -8.42% | 87 | 0 |
| Jun 30, 2025 | 92 | 0 | - | 92 | 0 |
| Mar 31, 2025 | 112 | 18 | 19.15% | 112 | 0 |
| Dec 31, 2024 | 104 | 2 | 1.96% | 104 | 0 |
| Sep 30, 2024 | 95 | -1 | -1.04% | 95 | 0 |
| Jun 30, 2024 | 92 | 4 | 4.55% | 92 | 0 |
| Mar 31, 2024 | 94 | 6 | 6.82% | 94 | 0 |
| Dec 31, 2023 | 102 | - | - | 101 | 1 |
| Sep 30, 2023 | 96 | - | - | 95 | 1 |
| Jun 30, 2023 | 88 | - | - | 88 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Humacyte | 184 |
| Innate Pharma | 164 |
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Nkarta | 106 |
| Armata Pharmaceuticals | 61 |
| Corbus Pharmaceuticals Holdings | 36 |
KRRO News
- 10 days ago - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Korro Bio reports Q2 EPS ($1.07), consensus ($1.28) - TheFly
- 18 days ago - Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 18 days ago - Korro Bio Quarterly report: Q2 2026 - Filings
- 18 days ago - Korro Bio Earnings release: Q2 2026 - Filings
- 6 weeks ago - Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Korro Bio initiated with an Outperform at LifeSci Capital - TheFly
- 3 months ago - Korro to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire